2.1 Comprehensive Patient Assessment & Medical History
Key Takeaways
- Chronic corticosteroid use (e.g., prednisone ≥ 20 mg/day) significantly impairs fibroblast proliferation and collagen synthesis, elevating the risk of mucocutaneous separation, stomal necrosis, and peristomal pyoderma gangrenosum; preoperative Vitamin A (10,000–25,000 IU/day orally or topically) counteracts steroid-induced healing deficits.
- Preoperative serum prealbumin (transthyretin; half-life 2–3 days, normal 15–36 mg/dL) is the most sensitive biomarker for acute protein-calorie deficits (< 10–11 mg/dL indicates severe malnutrition), whereas serum albumin (< 3.0–3.5 g/dL, half-life 18–20 days) reflects chronic protein depletion, visceral stores, and systemic inflammation.
- Anti-angiogenic targeted biologics (e.g., bevacizumab) must be discontinued at least 6 to 8 weeks prior to elective ostomy surgery due to life-threatening risks of severe wound dehiscence, anastomotic breakdown, and spontaneous bowel perforation.
- In Inflammatory Bowel Disease (IBD), differentiating Crohn's disease (transmural, skip lesions, fistulizing risk, non-curative) from Ulcerative Colitis (mucosal, continuous, curative with proctocolectomy) dictates surgical diversion configuration (end vs. loop vs. continent reservoir) and long-term surveillance.
- Preoperative baseline functional assessment must systematically evaluate manual dexterity, grip strength, visual acuity, and cognitive status to select appropriate pouching systems (pre-cut vs. cut-to-fit, one-piece vs. two-piece, drainable velcro vs. rigid clamp).
Comprehensive Patient Assessment & Medical History
Quick Answer: Preoperative assessment in ostomy care is a multidimensional evaluation that encompasses the underlying surgical etiology, systemic pharmacology, nutritional-metabolic reserve, physical sensory-motor capabilities, and abdominal wall topography. A structured assessment allows the Certified Ostomy Care Nurse (COCN) to anticipate surgical complexity, identify high-risk healing impairments (such as chronic corticosteroid or anti-angiogenic therapy), address severe protein-calorie malnutrition, and select an individualized pouching system tailored to the patient's visual and manual dexterity.
The successful rehabilitation of an individual undergoing fecal or urinary diversion begins well before the first surgical incision. Preoperative assessment is not merely a data-collection exercise; it is an active clinical risk-stratification process that directly informs surgical planning, stoma site selection, postoperative appliance fitting, and long-term self-care mastery.
1. Preoperative Patient History & Surgical Indications
The primary disease process dictating the creation of a stoma governs the type of diversion (ileostomy, colostomy, urostomy), whether the stoma is temporary or permanent, the expected effluent characteristics, and the likelihood of disease recurrence in the peristomal tissue.
Inflammatory Bowel Disease (IBD): Crohn's Disease vs. Ulcerative Colitis
Accurately distinguishing between Crohn's Disease (CD) and Ulcerative Colitis (UC) is paramount because their pathophysiological behavior directly affects surgical outcomes and stoma viability.
| Clinical & Pathological Feature | Crohn's Disease (CD) | Ulcerative Colitis (UC) |
|---|---|---|
| Anatomical Distribution | Any segment of the GI tract (mouth to anus); characteristically exhibits "skip lesions" with intervening healthy bowel. | Confined strictly to the large bowel (colon and rectum); continuous mucosal involvement starting from the anal verge extending proximally. |
| Depth of Inflammation | Transmural (full thickness: mucosa, submucosa, muscularis, serosa). | Mucosal and Submucosal only; muscularis propria is spared except in toxic megacolon. |
| Surgical Curability | Non-curative; surgical resection removes diseased segments but disease frequently recurs at anastomotic or stomal sites. | Curative with total proctocolectomy (removal of entire colon and rectum). |
| Continent Reservoirs (IPAA / Kock) | Strictly Contraindicated due to catastrophic pouch failure, fistula formation, and recurrent inflammation in the reservoir. | Standard Option (Ileal Pouch-Anal Anastomosis / J-Pouch or Continent Ileostomy / Kock Pouch). |
| Peristomal Complications | High risk for peristomal fistulas, strictures, deep ulcerations, and Peristomal Pyoderma Gangrenosum (PPG). | Moderate risk for PPG; minimal risk for peristomal fistulas once proctocolectomy is complete. |
| Common Stoma Types | End ileostomy, loop ileostomy (diverting), or temporary loop colostomy. | End ileostomy (permanent post-proctocolectomy) or temporary diverting loop ileostomy (protecting IPAA). |
Colorectal Carcinoma & Neoadjuvant Therapy
Malignancies of the colon and rectum account for a substantial proportion of stoma surgeries. Clinical staging (TNM classification) dictates the surgical approach:
- Abdominoperineal Resection (APR): Performed for distal rectal carcinomas invading the sphincter complex; involves complete excision of the rectum, anus, and levator ani musculature, resulting in a permanent end sigmoid colostomy in the Left Lower Quadrant (LLQ).
- Low Anterior Resection (LAR): Performed for mid-to-upper rectal lesions with sphincter preservation; utilizes a coloanal or colorectal anastomosis protected by a temporary diverting loop ileostomy in the Right Lower Quadrant (RLQ) to reduce morbidity from subclinical anastomotic leaks.
- Neoadjuvant Radiation Therapy: Pelvic radiation therapy causes microvascular endarteritis obliterans, dermal fibrosis, reduced tissue elasticity, and delayed epithelialization. The peristomal skin within previous radiation fields is friable, prone to adhesive-related injury, and slow to heal.
Diverticular Disease & Hinchey Classification
Complicated diverticulitis of the sigmoid colon frequently necessitates emergency or staged surgical intervention:
- Hinchey Stage I (Pericolic Abscess) & Stage II (Pelvic/Retroperitoneal Abscess): Often managed with CT-guided percutaneous drainage and antibiotics; elective resection may involve primary anastomosis with or without a protective loop ileostomy.
- Hinchey Stage III (Purulent Peritonitis) & Stage IV (Feculent Peritonitis): Life-threatening perforations traditionally managed with a Hartmann's Procedure (resection of diseased sigmoid colon, closure of the distal rectal stump as a Hartmann's pouch, and exteriorization of the proximal descending/sigmoid colon as an end colostomy in the LLQ).
Bladder Carcinoma & Urological Pathologies
Muscle-invasive urothelial carcinoma ($T_2–T_4$), refractory neurogenic bladder, severe radiation cystitis, or intractable interstitial cystitis may require radical cystectomy:
- Ileal Conduit (Bricker Diversion): The gold-standard non-continent urinary diversion. An isolated 12–15 cm segment of terminal ileum (retaining its mesenteric vascular pedicle) is mobilized; ureters are anastomosed to the proximal end, and the distal end is brought through the right rectus muscle as a stoma discharging continuous urine mixed with mucus.
- Continent Cutaneous Urinary Reservoirs (e.g., Indiana Pouch): Utilizes detubularized right colon and terminal ileum with a plicated ileocecal valve mechanism, requiring clean intermittent catheterization (CIC) rather than an external pouch.
Acute Trauma, Mesenteric Ischemia, and Polyposis Syndromes
- Abdominal Trauma: Penetrating gunshot or stab wounds and blunt deceleration injuries may cause extensive devascularization or feculent contamination, requiring damage-control laparotomy, temporary bowel exteriorization, and staged abdominal wall reconstruction.
- Acute Mesenteric Ischemia: Thrombosis or embolism of the superior mesenteric artery leads to transmural bowel infarction, necessitating extensive resection and emergent stoma creation in patients who are hemodynamically unstable and acidotic.
- Familial Adenomatous Polyposis (FAP): Autosomal dominant mutation of the APC gene causing hundreds to thousands of adenomatous polyps; mandates prophylactic total proctocolectomy with end ileostomy or ileoanal pouch in early adulthood.
2. Medication Reconciliation & Surgical Wound Healing
A meticulous pharmacological review must identify agents that suppress immune surveillance, impair microvascular perfusion, inhibit collagen synthesis, or alter hemostasis.
+---------------------------------------------------------------------------------------------------+
| PHARMACOLOGICAL AGENTS & HEALING IMPAIRMENT MATRIX |
+---------------------------------------------------------------------------------------------------+
| Medication Class | Specific Agents | Mechanism of Impairment | Clinical Countermeasures |
+------------------------+---------------------------+--------------------------------+-------------------------------+
| Corticosteroids | Prednisone, | Inhibits TGF-beta, PDGF, | Administer Vitamin A |
| | Methylprednisolone, | macrophage chemotaxis, and | (10,000–25,000 IU/day PO) |
| | Dexamethasone | prolyl hydroxylase; causes | preop; taper steroids if |
| | (≥ 20 mg/day) | severe skin atrophy. | clinically permissible. |
+------------------------+---------------------------+--------------------------------+-------------------------------+
| Biologics & | Infliximab, Adalimumab, | Blunts TNF-alpha inflammatory | Coordinate perioperative |
| Immunomodulators | Vedolizumab, Ustekinumab, | signaling; increases risk of | timing with gastroenterology; |
| | Methotrexate, Azathioprine| opportunistic wound infection | monitor for peristomal |
| | | and delayed closure. | sepsis. |
+------------------------+---------------------------+--------------------------------+-------------------------------+
| Anti-Angiogenics | Bevacizumab (Avastin), | Blocks VEGF receptors; halts | Mandatory 6 to 8 week washout |
| & Tyrosine Kinase Inh. | Sunitinib, Sorafenib | capillary sprouting; causes | prior to elective surgery; |
| | | catastrophic wound dehiscence. | delay postop restart 4-6 wks. |
+------------------------+---------------------------+--------------------------------+-------------------------------+
| Anticoagulants & | Warfarin, DOACs | Disrupts fibrin clot scaffold; | Follow bridging protocols; |
| Antiplatelets | (Apixaban, Rivaroxaban), | high risk of parastomal | monitor stomal mucosal |
| | Aspirin, Clopidogrel | hematoma and mucosal bleeding. | bleeding; avoid trauma. |
+------------------------+---------------------------+--------------------------------+-------------------------------+
| NSAIDs | Ketorolac, Ibuprofen, | Inhibits COX-1/COX-2; blunts | Discontinue preoperatively; |
| | Naproxen, Meloxicam | early inflammation and | use multimodal opioid- |
| | | increases anastomotic leak. | sparing analgesia. |
+------------------------+---------------------------+--------------------------------+-------------------------------+
Clinical Management of Corticosteroids
Patients with IBD or rheumatologic conditions taking $\ge 20\text{ mg/day}$ of prednisone for more than 2 to 3 weeks experience profound suppression of early wound healing:
- Mechanism: Corticosteroids stabilize lysosomal membranes, suppress monocyte-to-macrophage transformation, decrease vascular endothelial growth factor (VEGF) secretion, and block fibroblast collagen production.
- WOC Nursing Action: Preoperative or postoperative administration of Vitamin A (10,000 to 25,000 IU orally daily for 10 to 14 days, or topical Vitamin A) restores lysosomal labilization, stimulates macrophage recruitment, and partially restores collagen cross-linking without abrogating the systemic anti-inflammatory benefits of the steroid.
The Critical Washout Window for Anti-Angiogenics
Monoclonal antibodies targeting VEGF (such as bevacizumab) completely arrest microvascular angiogenesis:
- Surgical Danger: Operating on a patient receiving active bevacizumab therapy carries an extreme risk of spontaneous bowel perforation, total abdominal wound dehiscence, and stomal mucocutaneous separation.
- Protocol: Clinical guidelines mandate a minimum 6 to 8 week discontinuation window before elective abdominal surgery, and therapy should not be resumed postoperatively for at least 4 to 6 weeks until fascial and mucosal healing are fully established.
3. Nutritional Assessment & Metabolic Biomarkers
Protein-calorie malnutrition is an independent predictor of stomal complications, including mucocutaneous separation, stomal retraction, fascial dehiscence, and parastomal herniation.
Serum Protein Biomarkers: Albumin vs. Prealbumin vs. Transferrin
| Biomarker | Biological Half-Life | Normal Serum Range | Clinical Interpretation in Ostomy Preoperative Care |
|---|---|---|---|
| Prealbumin (Transthyretin) | 2 to 3 days | $15 - 36\text{ mg/dL}$ | Most sensitive indicator of acute nutritional change. Value $< 10 - 11\text{ mg/dL}$ indicates severe acute protein-calorie deficiency. Highly responsive to preoperative nutritional repletion (refeeding velocity). |
| Serum Albumin | 18 to 20 days | $3.5 - 5.0\text{ g/dL}$ | Indicator of chronic nutritional status and systemic inflammation. Negative acute-phase reactant (drops during sepsis, trauma, inflammation due to capillary leak). Value $< 3.0\text{ g/dL}$ correlates strongly with postoperative stomal retraction, edema, and anastomotic breakdown. |
| Transferrin | 8 days | $200 - 380\text{ mg/dL}$ | Intermediate sensitivity; influenced by iron stores (falsely elevated in iron-deficiency anemia, depressed in chronic inflammation). |
Essential Micronutrients in Wound Healing
- Zinc (Normal: $70 - 120\mu\text{g/dL}$): Essential enzyme cofactor for DNA/RNA synthesis, fibroblast proliferation, and matrix metalloproteinase (MMP) activity. Severe deficiency leads to delayed epithelialization and peristomal acrodermatitis enteropathica-like eruptions.
- Vitamin C (Ascorbic Acid): Obligate cofactor for prolyl and lysyl hydroxylase, which catalyze the triple-helix cross-linking of collagen fibers. Deficiency produces scurvy, capillary fragility, and stomal mucocutaneous dehiscence.
- Vitamin A: Essential for epithelial cell differentiation, immune function, and reversal of steroid-induced healing arrest.
- Vitamin D ($25\text{-OH Vitamin D}$): Regulates calcium homeostasis, neuromuscular function, and systemic immune defenses.
Anthropometrics & Weight Kinetics
- Body Mass Index (BMI):
- $\text{BMI} < 18.5\text{ kg/m}^2$: Cachexia/malnutrition; high risk of skin breakdown, prominent bony landmarks interfering with wafer adhesion.
- $\text{BMI} > 30 - 35\text{ kg/m}^2$: Obesity; deep abdominal creases, short/thick bowel mesentery (elevating tension on the stomal exteriorization), and risk of stomal retraction.
- $\text{BMI} > 40\text{ kg/m}^2$: Severe obesity; large pendulous panniculus requiring upper-quadrant stoma placement.
- Unintentional Weight Loss: Loss of $> 5%$ of body weight over 1 month or $> 10%$ over 6 months denotes severe nutritional compromise requiring aggressive preoperative dietetic optimization.
4. Physical Mobility, Dexterity, Visual Acuity & Cognitive Function
The physical ability of a patient to independently perform pouch changes dictates the design and complexity of the ostomy containment system selected.
+---------------------------------------------------------------------------------------+
| FUNCTIONAL CAPACITY & APPLIANCE ADAPTATION |
+---------------------------------------------------------------------------------------+
| Functional Domain | Clinical Deficit / Screening | Pouching System Modification |
+----------------------+-------------------------------------+----------------------------------+
| Manual Dexterity | Severe osteoarthritis, tremors, | - Pre-cut skin barriers |
| & Fine Motor Control | Parkinson's, post-stroke hemiparesis| - Integrated velcro tail closures|
| | (Inability to use scissors/clamps) | - Flexible 1-piece adhesive pouch|
+----------------------+-------------------------------------+----------------------------------+
| Visual Acuity | Macular degeneration, diabetic | - Pre-cut barriers (no tracing) |
| & Visual Fields | retinopathy, advanced cataracts | - High-contrast pouch borders |
| | (Inability to see stoma margin) | - Clear transparent front film |
+----------------------+-------------------------------------+----------------------------------+
| Physical Mobility | Kyphosis, lordosis, wheelchair | - Stoma marked above fold/thigh |
| & Spinal Flexibility | confinement, severe joint contracture| - Extended wear flexible barrier|
| | (Inability to bend to lower abdomen)| - Convexity if flush in creases |
+----------------------+-------------------------------------+----------------------------------+
| Cognitive Function | Dementia, delirium risk, low | - Simplified 1-piece system |
| & Health Literacy | executive function (MMSE < 24) | - Pictorial instructions |
| | (Inability to follow 5-step change) | - Mandatory caregiver training |
+----------------------+-------------------------------------+----------------------------------+
Evaluating Manual Dexterity
The COCN must evaluate the patient's fine motor skills before surgery:
- Have the patient manipulate a sample pouch: open and close an integrated velcro closure (e.g., Lock 'n Roll), snap a two-piece mechanical flange together, and peel adhesive backing paper.
- Patients with severe rheumatoid hand deformities or tremors struggle with rigid plastic two-piece mechanical coupling rings (which require $10 - 15\text{ lbs}$ of perpendicular pressure directly against a fresh, tender surgical abdomen). In these individuals, a one-piece flexible system or a two-piece adhesive-coupling system (foam tape latch) is indicated.
Visual Acuity Adaptations
Patients with visual impairments (e.g., visual acuity worse than 20/70) cannot accurately trace and cut a skin barrier with curved scissors, predisposing them to cutting the opening off-center or leaving exposed peristomal skin susceptible to severe chemical irritant dermatitis. These patients require factory pre-cut skin barriers sized precisely to their post-edema stoma dimensions.
5. Dynamic Abdominal Contour Assessment
An accurate abdominal assessment requires evaluating the patient in multiple postures to identify how gravity, muscle tone, and body habitus alter the abdominal surface.
Systematic 4-Position Examination Protocol
- Supine (Lying Flat): Palpate the lateral and medial borders of the rectus abdominis muscle. Perform the "head-lift" or "leg-raise" maneuver (asking the patient to lift their head off the bed or raise their legs) to tense the rectus sheath, confirming its precise anatomical location.
- Sitting Upright (and Bending Forward): This is the most revealing position. Sitting forces the intra-abdominal contents forward and exposes deep transverse adipose folds, pendulous pannus overhang, waistline indentations, and thigh impingement zones that disappear completely when supine.
- Standing: Evaluates the gravitational pull on the lower abdomen, the natural drape of clothing, the location of the patient's beltline, and overall postural alignment.
- Bending / Twisting: Verifies that the designated peristomal area maintains a flat $2 - 3\text{ inch}$ ($5.0 - 7.5\text{ cm}$) radius during dynamic torso movements.
Topographical Landmarks & Challenging Features
- Scars & Incision Lines: Stomas placed closer than $2\text{ inches}$ ($5\text{ cm}$) to an existing laparotomy scar, drain site, or previous stoma scar will experience chronic pouch leakage due to adhesive bridging across the scar trough.
- Umbilicus & Groin Creases: Placing a stoma too close to the umbilicus or inguinal crease prevents the adhesive barrier from adhering evenly, causing rapid undermining of effluent.
- Pendulous Pannus (Abdominal Apron): In patients with significant central obesity, placing a stoma below the crest of the pannus buries the stoma in a dark, moist, anaerobic subpannicular fold where the patient cannot visualize it, leading to recurrent fungal infections and impossible appliance maintenance.
A 48-year-old patient with severe Crohn's disease who has been maintained on oral prednisone 30 mg daily for the past 6 months is scheduled for an elective proctocolectomy and end ileostomy. What preoperative pharmacological intervention should the Certified Ostomy Care Nurse recommend to the surgical team to counteract corticosteroid-induced suppression of fibroblast activity and collagen synthesis?
A 66-year-old patient with obstructive rectal carcinoma and a 15% unintentional weight loss over 3 months is being evaluated prior to low anterior resection with diverting loop ileostomy. Which laboratory biomarker provides the most sensitive and clinically responsive indicator of acute protein-calorie nutritional repletion over a 48- to 72-hour window?
A 59-year-old patient with metastatic colon cancer receiving second-line chemotherapy including bevacizumab (Avastin) is scheduled for palliative sigmoid colostomy creation to relieve impending malignant obstruction. According to surgical and wound care safety guidelines, what is the mandatory minimum preoperative discontinuation window required for bevacizumab before elective surgery?
A 74-year-old patient with severe bilateral hand tremors due to Parkinson's disease and moderate macular degeneration is scheduled for a permanent end sigmoid colostomy. When planning preoperative education and appliance selection, which ostomy pouching system configuration is most appropriate to promote patient self-care independence?